On Open-Label Study in Participants With Systemic Lupus Erythematosus

NCT01488708 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1518

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy

Conditions

Systemic Lupus Erythematosus
Connective Tissue Disease
Autoimmune Disease

Interventions

DRUG: LY2127399
DRUG: Placebo

Sponsor

Eli Lilly and Company